TLDR:
- Harikesh Pushpapathan promoted to partner at Stoic Venture Capital, a life sciences and deep tech VC.
- Stoic’s investments focus on university-led startups, with a particular emphasis on funding research and innovation.
Harikesh Pushpapathan named partner at Stoic Venture Capital
Life sciences and deep tech VC Stoic Venture Capital has promoted Harikesh Pushpapathan to partner at the fund. Pushpapathan, who joined Stoic in early 2022 as an investment analyst, has a background in psychology, neuroscience, and finance from the University of Sydney.
The fund’s investments primarily focus on supporting university-led startups, with a strong emphasis on funding research and innovation that can extend and enhance human life. Pushpapathan’s scientific academic background has played a crucial role in supporting this mission.
Stoic’s investments include various startups such as chip maker Morse Micro, pharmaceutical startup Ena, Wildlife Drones, and cardiac rehabilitation platform Cardihab. Guy Hedley, Stoic’s general partner and co-founder, highlighted Pushpapathan’s role in bridging the gap between investees and the fund’s fundraising efforts.
Pushpapathan expressed his excitement over being named a partner at the VC, emphasizing his particular interest in neurotechnology and the rewarding experience of supporting startups addressing critical health issues. Overall, Stoic’s unique approach involves supporting scientists and inventors through the complex journey of research commercialization.
